why choose us

Clinical Trials Search

Showing 8,330 of 132,656 result(s)
A Smartphone-Based Intervention to Improve Colorectal Cancer Screening in African American Men

Status: NOT_YET_RECRUITING

Condition: Colorectal Cancer

Interventions: Participants receive text messages that contain information about colorectal cancer and screening.
Some text messages include links to videos tha

Date: 2023-09-18

Left Atrial Appendage Closure With WATCHMAN FLX Device in Recurrent Gastrointestinal Bleeding: The GI-FLX Registry

Status: Completed

Condition: Atrial Fibrillation

Interventions: LAAC with Watchman FLX device

Date: 2023-09-18

Implementing and Evaluating the Integration of Physical Activity Into a Major Health System and Connecting Patients to Physical Activity Programs.

Status: Completed

Condition: Chronic Disease

Interventions: All eligible Prisma Health clinics will be invited to adopt EIMG.
Adopting clinics will first be sent an instructional video as a part of a low t

Date: 2023-09-18

Hepatic Encephalopathy and Albumin Lasting Cognitive Improvement

Status: Completed

Condition: Cirrhosis

Interventions: Intravenous human serum albumin to be given at 1.5g;kg ideal body weight

Date: 2023-09-18

Augmented Reality for Subdural Drain Placement

Status: NOT_YET_RECRUITING

Condition: Subdural Hematoma

Interventions: AR device will be used to determine where to place SEPS drain

Date: 2023-09-18

Bumetanide in Patients With Alzheimer's Disease

Status: NOT_YET_RECRUITING

Condition: Alzheimer Disease

Interventions: Bumetanide is an FDA approved loop diuretic that has been used for more than three decades to treat edema, congestive heart failure, and hypertension

Date: 2023-09-18

A Study Following Women in Menopause Treated With a Non-hormonal Therapy for Hot Flashes and Night Sweats

Status: Completed

Condition: Hot Flashes

Interventions: Oral

Date: 2023-09-18

Gaps in Periodontal Care in Cirrhosis

Status: Completed

Condition: Cirrhosis

Interventions: Dental exam and periodontal cleaning if needed

Date: 2023-09-18

A Study to Evaluate Efficacy and Safety of Tulisokibart (MK-7240) in Participants With Moderately to Severely Active Ulcerative Colitis (MK-7240-001)

Status: Completed

Condition: Ulcerative Colitis

Interventions: Humanized monoclonal antibody that binds human tumor necrosis factor-like cytokine 1A (TL1A), administered intravenously

Date: 2023-09-18

Sing For Your Saunter Part 2 R33

Status: Completed

Condition: Parkinson Disease

Interventions: Group classes led by a music therapist and using singing as a self-generated cue, with a focus on rhythm perception, rhythm generation and synchroniza

Date: 2023-09-18